SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-187189
Filing Date
2022-07-01
Accepted
2022-07-01 16:06:52
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d346782ds3.htm S-3 540136
2 EX-4.4 d346782dex44.htm EX-4.4 525226
3 EX-4.6 d346782dex46.htm EX-4.6 564147
4 EX-5.1 d346782dex51.htm EX-5.1 66468
5 EX-5.2 d346782dex52.htm EX-5.2 12970
6 EX-23.3 d346782dex233.htm EX-23.3 1467
7 EX-FILING FEES d346782dexfilingfees.htm EX-FILING FEES 50177
8 GRAPHIC g346782g01a03.jpg GRAPHIC 75039
9 GRAPHIC g346782g0630064446281.jpg GRAPHIC 2648
  Complete submission text file 0001193125-22-187189.txt   1869043
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-265978 | Film No.: 221061415
SIC: 2834 Pharmaceutical Preparations